Global Opioids Agonist Drugs Market Research Report 2019

Table of Contents

Executive Summary

1 Opioids Agonist Drugs Market Overview

• 1.1 Product Overview and Scope of Opioids Agonist Drugs
• 1.2 Opioids Agonist Drugs Segment by Type
  • 1.2.1 Global Opioids Agonist Drugs Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Codeine
  • 1.2.3 Fentanyl
  • 1.2.4 Meperidine
  • 1.2.5 Methadone
  • 1.2.6 Morphine
  • 1.2.7 Hydrocodone
• 1.3 Opioids Agonist Drugs Segment by Application
  • 1.3.1 Opioids Agonist Drugs Consumption Comparison by Application (2014-2025)
  • 1.3.2 Pain Management
  • 1.3.3 Cough Treatment
  • 1.3.4 Diarrhea Treatment
• 1.4 Global Opioids Agonist Drugs Market by Region
  • 1.4.1 Global Opioids Agonist Drugs Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Opioids Agonist Drugs Market Size
  • 1.5.1 Global Opioids Agonist Drugs Revenue (2014-2025)
  • 1.5.2 Global Opioids Agonist Drugs Production (2014-2025)

2 Global Opioids Agonist Drugs Market Competition by Manufacturers

• 2.1 Global Opioids Agonist Drugs Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Opioids Agonist Drugs Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Opioids Agonist Drugs Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Opioids Agonist Drugs Production Sites, Area Served, Product Types
• 2.5 Opioids Agonist Drugs Market Competitive Situation and Trends
  • 2.5.1 Opioids Agonist Drugs Market Concentration Rate
  • 2.5.2 Opioids Agonist Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Opioids Agonist Drugs Production Market Share by Regions

• 3.1 Global Opioids Agonist Drugs Production Market Share by Regions
• 3.2 Global Opioids Agonist Drugs Revenue Market Share by Regions (2014-2019)
• 3.3 Global Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Opioids Agonist Drugs Production
  • 3.4.1 North America Opioids Agonist Drugs Production Growth Rate (2014-2019)
  • 3.4.2 North America Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Opioids Agonist Drugs Production
  • 3.5.1 Europe Opioids Agonist Drugs Production Growth Rate (2014-2019)
  • 3.5.2 Europe Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Opioids Agonist Drugs Production (2014-2019)
  • 3.6.1 China Opioids Agonist Drugs Production Growth Rate (2014-2019)
  • 3.6.2 China Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Opioids Agonist Drugs Production (2014-2019)
  • 3.7.1 Japan Opioids Agonist Drugs Production Growth Rate (2014-2019)
  • 3.7.2 Japan Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Opioids Agonist Drugs Consumption by Regions

• 4.1 Global Opioids Agonist Drugs Consumption by Regions
• 4.2 North America Opioids Agonist Drugs Consumption (2014-2019)
• 4.3 Europe Opioids Agonist Drugs Consumption (2014-2019)
• 4.4 China Opioids Agonist Drugs Consumption (2014-2019)
• 4.5 Japan Opioids Agonist Drugs Consumption (2014-2019)

5 Global Opioids Agonist Drugs Production, Revenue, Price Trend by Type

• 5.1 Global Opioids Agonist Drugs Production Market Share by Type (2014-2019)
• 5.2 Global Opioids Agonist Drugs Revenue Market Share by Type (2014-2019)
• 5.3 Global Opioids Agonist Drugs Price by Type (2014-2019)
• 5.4 Global Opioids Agonist Drugs Production Growth by Type (2014-2019)

6 Global Opioids Agonist Drugs Market Analysis by Applications

• 6.1 Global Opioids Agonist Drugs Consumption Market Share by Application (2014-2019)
• 6.2 Global Opioids Agonist Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Opioids Agonist Drugs Business

• 7.1 Purdue Pharma
  • 7.1.1 Purdue Pharma Opioids Agonist Drugs Production Sites and Area Served
  • 7.1.2 Opioids Agonist Drugs Product Introduction, Application and Specification
  • 7.1.3 Purdue Pharma Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Titan pharmaceuticals
  • 7.2.1 Titan pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
  • 7.2.2 Opioids Agonist Drugs Product Introduction, Application and Specification
  • 7.2.3 Titan pharmaceuticals Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Boehringer Ingelheim
  • 7.3.1 Boehringer Ingelheim Opioids Agonist Drugs Production Sites and Area Served
  • 7.3.2 Opioids Agonist Drugs Product Introduction, Application and Specification
  • 7.3.3 Boehringer Ingelheim Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Janssen Pharmaceuticals, Inc
  • 7.4.1 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Production Sites and Area Served
  • 7.4.2 Opioids Agonist Drugs Product Introduction, Application and Specification
  • 7.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Sanofi
  • 7.5.1 Sanofi Opioids Agonist Drugs Production Sites and Area Served
  • 7.5.2 Opioids Agonist Drugs Product Introduction, Application and Specification
  • 7.5.3 Sanofi Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Sun Pharmaceuticals
  • 7.6.1 Sun Pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
  • 7.6.2 Opioids Agonist Drugs Product Introduction, Application and Specification
  • 7.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Mallinckrodt Pharmaceuticals
  • 7.7.1 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
  • 7.7.2 Opioids Agonist Drugs Product Introduction, Application and Specification
  • 7.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Egalet Corporation
  • 7.8.1 Egalet Corporation Opioids Agonist Drugs Production Sites and Area Served
  • 7.8.2 Opioids Agonist Drugs Product Introduction, Application and Specification
  • 7.8.3 Egalet Corporation Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Endo Pharmaceuticals Inc.
  • 7.9.1 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Production Sites and Area Served
  • 7.9.2 Opioids Agonist Drugs Product Introduction, Application and Specification
  • 7.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Allergan, Plc
  • 7.10.1 Allergan, Plc Opioids Agonist Drugs Production Sites and Area Served
  • 7.10.2 Opioids Agonist Drugs Product Introduction, Application and Specification
  • 7.10.3 Allergan, Plc Opioids Agonist Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Pfizer Inc

8 Opioids Agonist Drugs Manufacturing Cost Analysis

• 8.1 Opioids Agonist Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Opioids Agonist Drugs
• 8.4 Opioids Agonist Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Opioids Agonist Drugs Distributors List
• 9.3 Opioids Agonist Drugs Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Opioids Agonist Drugs Market Forecast

• 11.1 Global Opioids Agonist Drugs Production, Revenue Forecast
  • 11.1.1 Global Opioids Agonist Drugs Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Opioids Agonist Drugs Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Opioids Agonist Drugs Price and Trend Forecast (2019-2025)
• 11.2 Global Opioids Agonist Drugs Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Opioids Agonist Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Opioids Agonist Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Opioids Agonist Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Opioids Agonist Drugs Production, Revenue Forecast (2019-2025)
• 11.3 Global Opioids Agonist Drugs Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Opioids Agonist Drugs Consumption Forecast (2019-2025)
  • 11.3.2 Europe Opioids Agonist Drugs Consumption Forecast (2019-2025)
  • 11.3.3 China Opioids Agonist Drugs Consumption Forecast (2019-2025)
  • 11.3.4 Japan Opioids Agonist Drugs Consumption Forecast (2019-2025)
• 11.4 Global Opioids Agonist Drugs Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Opioids Agonist Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List